...
首页> 外文期刊>Applied and Environmental Microbiology >Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens.
【24h】

Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens.

机译:产气荚膜梭菌结合胆汁酸水解酶基因的克隆和鉴定。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The gene encoding a conjugated bile acid hydrolase (CBAH) from Clostridium perfringens 13 has been cloned and expressed in Escherichia coli, and its nucleotide sequence has been determined. Nucleotide and predicted amino acid sequence analyses indicated that the gene product is related to two previously characterized amidases, a CBAH from Lactobacillus plantarum (40% identity) and a penicillin V amidase from Bacillus sphaericus (34% identity). The product is apparently unrelated to a CBAH from C. perfringens for which N-terminal sequence information was determined. The gene product was purified from recombinant E. coli and used to raise antibody in rabbits. The presence of the protein in C. perfringens was then confirmed by immunoblot analysis. The protein was shown to have a native molecular weight of 147,000 and a subunit molecular weight of 36,100, indicating its probable existence as a tetramer. Disruption of the chromosomal C. perfringens CBAH gene with a chloramphenicol resistance cartridge resulted in a mutant strain which retained partial CBAH activity. Polyacrylamide gel electrophoresis followed by enzymatic activity staining and immunoblotting indicated that the mutant strain no longer expressed the cloned CBAH (CBAH-1) but did express at least one additional CBAH (CBAH-2). CBAH-2 was immunologically distinct from CBAH-1, and its mobility on native polyacrylamide gels was different from that of CBAH-1. Furthermore, comparisons of pH optima and substrate specificities of CBAH activities from recombinant E. coli and wild-type and mutant C. perfringens provided further evidence for the presence of multiple CBAH activities in C. perfringens.
机译:来自产气荚膜梭菌13的编码共轭胆汁酸水解酶(CBAH)的基因已被克隆并在大肠杆菌中表达,并已确定其核苷酸序列。核苷酸和预测的氨基酸序列分析表明,该基因产物与两种先前表征的酰胺酶有关,一种来自植物乳杆菌的CBAH(40%相同性)和一种来自球形芽孢杆菌的青霉素V酰胺酶(34%相同性)。该产物显然与产气荚膜梭菌的CBAH无关,已确定了其N端序列信息。从重组大肠杆菌中纯化该基因产物,并用于在兔中产生抗体。然后通过免疫印迹分析确认产气荚膜梭菌中蛋白质的存在。该蛋白质显示出其天然分子量为147,000,亚单位分子量为36,100,表明其可能以四聚体形式存在。用氯霉素抗性药筒破坏产气荚膜梭状芽胞杆菌CBAH基因,导致突变株保留了部分CBAH活性。聚丙烯酰胺凝胶电泳,然后进行酶活性染色和免疫印迹表明,突变株不再表达克隆的CBAH(CBAH-1),但确实表达了至少一种另外的CBAH(CBAH-2)。 CBAH-2在免疫学上与CBAH-1不同,并且它在天然聚丙烯酰胺凝胶上的移动性与CBAH-1不同。此外,对pH最佳值和重组大肠杆菌以及野生型和突变产气荚膜梭状芽胞杆菌的CBAH活性的底物特异性的比较,为产气荚膜梭菌中存在多种CBAH活性提供了进一步的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号